A Multicentric, Randomized, Controlled Phase III Study of Centhaquine (Lyfaquin®) as a Resuscitative Agent in Hypovolemic Shock Patients.

Anil GulatiRajat ChoudhuriAjay GuptaSaurabh SinghS K Noushad AliGursaran Kaur SidhuParvez David HaquePrashant RahateAditya R BothraGyan P SinghSanjiv MaheshwariDeepak JeswaniSameer HaveriApurva AgarwalNilesh Radheshyam Agrawal

Published in: Drugs (2021)

Clinical Trials Registry, India; ctri.icmr.org.in, CTRI/2019/01/017196; clinicaltrials.gov, NCT04045327.

Keyphrases

phase iii
clinical trial
open label
double blind
phase ii
end stage renal disease
placebo controlled
chronic kidney disease
newly diagnosed
ejection fraction
peritoneal dialysis
prognostic factors
study protocol